
    
      The main objective of the study is to explore the effect of EligardÂ® on the following
      prostate cancer biomarkers:

      Testosterone in serum, Prostate Specific Antigen (PSA) in serum, Prostate Cancer Antigen
      (PCA3 score) in urine, PSA mRNA in blood/Peripheral Blood Mononuclear Cell (PBMC), PCA3 mRNA
      in blood/PBMC, Transmembrane protease, serine 2-Ets Related Gene (TMPRSS2-ERG) mRNA in
      blood/PBMC

      A blood sample for RNA analysis will also be collected and stored for future investigation in
      patients giving specific informed consent.
    
  